Accounting for the impact of rare variants on causal inference with RARE: a novel multivariable Mendelian randomization method
Briefings in Bioinformatics · 2025
DOI: 10.1093/bib/bbaf214 ↗Kurz gefasst
Fachartikel in der Zeitschrift Briefings in Bioinformatics, 2025. Verfasst von Yu Cheng und 9 weiteren Autor:innen. Beteiligte Einrichtung: Research Center of Biostatistics and Computational Pharmacy, China Pharmaceutical University, #639 Longmian Ave, Jiangning District, Nanjing 211100, …. Hauptthemen laut MEDLINE: Mendelian Randomization Analysis, Genetic Variation. Die Arbeit nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Fundamental Research Funds for the Central Universities of China Pharmaceutical University, National Natural Science Foundation of China, National Science Foundation for Young Scientists of China.
Abstract (Originalsprache)
Mendelian randomization (MR) method utilizes genetic variants as instrumental variables to infer the causal effect of an exposure on an outcome. However, the impact of rare variants on traits is often neglected, and traditional MR assumptions can be violated by correlated horizontal pleiotropy (CHP) and uncorrelated horizontal pleiotropy (UHP). To address these issues, we propose a multivariable MR approach, an extension of the standard MR framework: MVMR incorporating Rare variants Accounting for multiple Risk factors and shared horizontal plEiotropy (RARE). In the simulation studies, we demonstrate that RARE effectively detects the causal effects of exposures on outcome with accounting for the impact of rare variants on causal inference. Additionally, we apply RARE to study the effects of high density lipoprotein and low density lipoprotein on type 2 diabetes and coronary atherosclerosis, respectively, thereby illustrating its robustness and effectiveness in real data analysis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Research Center of Biostatistics and Computational Pharmacy, China Pharmaceutical University, #639 Longmian Ave, Jiangning District, Nanjing 211100, Jiangsu, China.
- Department of Bioinformatics and Computational Biology, The University of Texas, M.D. Anderson Cancer Center, #7007 Bertner Ave, Texas Medical Center, Houston 77030, TX, United States.
- Department of Cancer and Functional Genomics, Institute of Genetics and Molecular and Cellular Biology, CNRS/INSERM/UNISTRA, #10142 BP, Illkirch 67400, Bas-Rhin, France.
- High School Affiliated to Nanjing Normal University, #37 Chahar Road, Gulou District, Nanjing 210003, Jiangsu, China.
- Department of Biochemistry, Vassar college, Poughkeepsie, NY 12604, United States.
Förderung
- Fundamental Research Funds for the Central Universities of China Pharmaceutical University
- National Natural Science Foundation of China
- National Science Foundation for Young Scientists of China
- 2024 National Key Research on Multi-Target Natural Drugs
- Key Laboratory of Scientific and Engineering Computing
- Shanghai Frontiers Science Center of Modern Analysis
Zitieren
APA
Cheng, Y., Ruan, X., Lu, X., Yang, Y., Wang, Y., Yan, S., Sun, Y., Yan, F., Jiang, L., & Liu, T. (2025). Accounting for the impact of rare variants on causal inference with RARE: a novel multivariable Mendelian randomization method. Briefings in Bioinformatics. https://doi.org/10.1093/bib/bbaf214
Vancouver
Cheng Y, Ruan X, Lu X, Yang Y, Wang Y, Yan S, et al. Accounting for the impact of rare variants on causal inference with RARE: a novel multivariable Mendelian randomization method. Briefings in Bioinformatics. 2025. doi:10.1093/bib/bbaf214
BibTeX
@article{Cheng2025,
author = {Cheng, Yu and Ruan, Xinjia and Lu, Xiaofan and Yang, Yuqing and Wang, Yuhang and Yan, Shangjin and Sun, Yuzhe and Yan, Fangrong and Jiang, Liyun and Liu, Tiantian},
title = {Accounting for the impact of rare variants on causal inference with RARE: a novel multivariable Mendelian randomization method},
journal = {Briefings in Bioinformatics},
year = {2025},
doi = {10.1093/bib/bbaf214}
}
EUVIMED